Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis11See Editorial by de Zeeuw, p. 1176.

Anderson, 1986, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, 1993, 10.1172/JCI112528 The GISEN Group, 1997, Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, nondiabetic nephropathy, Lancet, 349, 1857, 10.1016/S0140-6736(96)11445-8 Wolf, 1999, Angiotensin II: A pivotal factor in the progression of renal diseases, Nephrol Dial Transplant, 14, 42, 10.1093/ndt/14.suppl_1.42 Border, 1990, Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1, Nature, 346, 371, 10.1038/346371a0 Floege, 1991, Increased synthesis of extracellular matrix in mesangial proliferative nephritis, Kidney Int, 40, 477, 10.1038/ki.1991.235 Wenzel, 1997, Monocyte chemoattractant protein 1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis, Kidney Int, 51, 770, 10.1038/ki.1997.108 Peters, 2000, Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis, Kidney Int, 57, 1493, 10.1046/j.1523-1755.2000.00994.x Kiyma, 1994, Inhibitory effects of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum-induced mesangiolysis in spontaneously hypertensive rats, Life Sci, 54, 1891, 10.1016/0024-3205(94)90147-3 Wenzel, 1999, Effect of renovascular hypertension on experimental glomerulonephritis in rats, J Lab Clin Med, 134, 192, 10.1016/S0022-2143(99)90210-X Schneider, 1999, Monocyte chemoattractant protein 1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor beta, Kidney Int, 56, 135, 10.1046/j.1523-1755.1999.00543.x Wolf, 1999, Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats, Diabetologia, 42, 1425, 10.1007/s001250051314 Wenzel, 2000, Renovascular hypertension does not influence repair of the glomerular lesions induced by anti-thymocyte glomerulonephritis, Kidney Int, 58, 1135, 10.1046/j.1523-1755.2000.00270.x Cattel, 1994, Macrophages in acute glomerular inflammation, Kidney Int, 45, 945, 10.1038/ki.1994.128 Johnson, 1992, Renal injury from angiotensin II-mediated hypertension, Hypertens, 19, 464, 10.1161/01.HYP.19.5.464 Westerhuis, 2000, Distinctive roles of neutrophils and monocytes in anti-thy-1 nephritis, Am J Pathol, 156, 303, 10.1016/S0002-9440(10)64731-1 Wolf, 1997, Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor, J Clin Invest, 100, 1047, 10.1172/JCI119615 Stoll, 1995, The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells, J Clin Invest, 95, 651, 10.1172/JCI117710 Chevalier, 1999, Renal cellular response to ureteral obstruction: Role of maturation and angiotensin II, Am J Physiol, 277, F41 Song, 1998, Plasmid DNA encoding transforming growth factor beta 1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model, J Clin Invest, 101, 2615, 10.1172/JCI2480 Kitamura, 1997, Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-beta1, J Immunol, 159, 1404, 10.4049/jimmunol.159.3.1404 Wolf, 1993, Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta, J Clin Invest, 92, 1366, 10.1172/JCI116710 Kitamura, 1999, The concept of glomerular self-defense, Kidney Int, 55, 1639, 10.1046/j.1523-1755.1999.00425.x Braun Dullaeus, 1999, A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II-stimulated vascular smooth muscle cell hypertrophy, J Clin Invest, 104, 815, 10.1172/JCI5339 Wolf, 1996, Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1, Kidney Int, 50, 2112, 10.1038/ki.1996.537 Ophascharoensuk, 1998, The cyclin-kinase inhibitor p27 Kip1 safeguards against inflammatory injury, Nat Med, 4, 575, 10.1038/nm0598-575 Johnson, 1992, Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor, J Exp Med, 175, 1413, 10.1084/jem.175.5.1413 Palmer, 1966, Unilaterale glomerulonephritis. Virtual absence of nephritis in a kidney with partial occlusion of the main renal artery, Am J Med, 40, 816, 10.1016/0002-9343(66)90164-1 Zoja, 1998, Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis, Am J Kidney Dis, 31, 453, 10.1053/ajkd.1998.v31.pm9506682 Jackson, 1990, Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat, J Lab Clin Med, 115, 21 Fujinaka, 2000, Salutary role for angiotensin in partial urinary tract obstruction, Kidney Int, 58, 2018, 10.1111/j.1523-1755.2000.00374.x Vercauteren, 1999, Chronic reduction in renal mass in the rat attenuates ischemia/reperfusion injury and does not impair tubular regeneration, J Am Soc Nephrol, 10, 2551, 10.1681/ASN.V10122551 Gerner, 1975, Induced thermal resistance in HeLa cells, Nature, 256, 500, 10.1038/256500a0 Heemann, 2000, Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury. Possible connection to an interleukin-6-dependent pathway, Am J Pathol, 156, 287, 10.1016/S0002-9440(10)64729-3 Wenzel, 2001, ACE-inhibitor and progression of renal disease: evidence from clinical studies